WJ, G., CS, H., HAWM, T., MR, L., AT, H., O, S., . . . JD, C. (2026). The CFTR potentiator icenticaftor for treatment of bronchiectasis: An international phase 2, double-blind, randomized placebo-controlled trial. American journal of respiratory and critical care medicine, 212(6), 1343. https://doi.org/10.1093/ajrccm/aamag032
Chicago Style (17th ed.) CitationWJ, Guan, et al. "The CFTR Potentiator Icenticaftor for Treatment of Bronchiectasis: An International Phase 2, Double-blind, Randomized Placebo-controlled Trial." American Journal of Respiratory and Critical Care Medicine 212, no. 6 (2026): 1343. https://doi.org/10.1093/ajrccm/aamag032.
MLA (9th ed.) CitationWJ, Guan, et al. "The CFTR Potentiator Icenticaftor for Treatment of Bronchiectasis: An International Phase 2, Double-blind, Randomized Placebo-controlled Trial." American Journal of Respiratory and Critical Care Medicine, vol. 212, no. 6, 2026, p. 1343, https://doi.org/10.1093/ajrccm/aamag032.